These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1568 related items for PubMed ID: 9747818

  • 1. Phase I dose escalating trial of hyperfractionated pre-operative chemoradiation for locally advanced rectal cancer.
    Movsas B, Hanlon AL, Lanciano R, Scher RM, Weiner LM, Sigurdson ER, Hoffman JP, Eisenberg BL, Cooper HS, Provins S, Coia LR.
    Int J Radiat Oncol Biol Phys; 1998 Aug 01; 42(1):43-50. PubMed ID: 9747818
    [Abstract] [Full Text] [Related]

  • 2. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM).
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1129-39. PubMed ID: 16414206
    [Abstract] [Full Text] [Related]

  • 3. Phase II trial of preoperative chemoradiation with a hyperfractionated radiation boost in locally advanced rectal cancer.
    Movsas B, Diratzouian H, Hanlon A, Cooper H, Freedman G, Konski A, Sigurdson E, Hoffman J, Meropol NJ, Weiner LM, Coia L, Lanciano R, Stein J, Kister D, Eisenberg B.
    Am J Clin Oncol; 2006 Oct 15; 29(5):435-41. PubMed ID: 17023775
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome.
    Pucciarelli S, Toppan P, Friso ML, Russo V, Pasetto L, Urso E, Marino F, Ambrosi A, Lise M.
    Dis Colon Rectum; 2004 Nov 15; 47(11):1798-807. PubMed ID: 15622571
    [Abstract] [Full Text] [Related]

  • 6. Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients.
    Valentini V, Coco C, Picciocchi A, Morganti AG, Trodella L, Ciabattoni A, Cellini F, Barbaro B, Cogliandolo S, Nuzzo G, Doglietto GB, Ambesi-Impiombato F, Cosimelli M.
    Int J Radiat Oncol Biol Phys; 2002 Jul 01; 53(3):664-74. PubMed ID: 12062610
    [Abstract] [Full Text] [Related]

  • 7. Chemoradiotherapy followed by surgery in rectal cancer: improved local control using a moderately high pelvic radiation dose.
    Lee SH, Lee KC, Choi JH, Oh JH, Baek JH, Park SH, Shin DB.
    Jpn J Clin Oncol; 2008 Feb 01; 38(2):112-21. PubMed ID: 18263881
    [Abstract] [Full Text] [Related]

  • 8. Pre-operative chemoradiotherapy in locally advanced rectal cancer.
    Elsaleh H, Joseph D, Levitt M, House A, Robbins P.
    Aust N Z J Surg; 1999 Oct 01; 69(10):737-42. PubMed ID: 10527353
    [Abstract] [Full Text] [Related]

  • 9. [Preoperative concurrent radiochemotherapy for cancer of the rectum].
    Berger C, Kirscher S, Félix-Faure C, Chauvet B, Vincent P, Brewer Y, Reboul F.
    Cancer Radiother; 1998 Oct 01; 2(3):260-5. PubMed ID: 9749124
    [Abstract] [Full Text] [Related]

  • 10. Phase II clinical trial of preoperative combined chemoradiation for T3 and T4 resectable rectal cancer: preliminary results.
    Tjandra JJ, Reading DM, McLachlan SA, Gunn IF, Green MD, McLaughlin SJ, Millar JL, Pedersen JS.
    Dis Colon Rectum; 2001 Aug 01; 44(8):1113-22. PubMed ID: 11535850
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of preoperative radiation therapy for resectable rectal adenocarcinoma when combined with oral tegafur-uracil modulated with leucovorin: results from a phase II study.
    Uzcudun AE, Batlle JF, Velasco JC, Sánchez Santos ME, Carpeño Jde C, Grande AG, Juberías AM, Piñeiro EH, Olivar LM, García AG.
    Dis Colon Rectum; 2002 Oct 01; 45(10):1349-58. PubMed ID: 12394434
    [Abstract] [Full Text] [Related]

  • 12. Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum.
    Coia L, Hoffman J, Scher R, Weese J, Solin L, Weiner L, Eisenberg B, Paul A, Hanks G.
    Int J Radiat Oncol Biol Phys; 1994 Aug 30; 30(1):161-7. PubMed ID: 8083109
    [Abstract] [Full Text] [Related]

  • 13. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.
    Bonnen M, Crane C, Vauthey JN, Skibber J, Delclos ME, Rodriguez-Bigas M, Hoff PM, Lin E, Eng C, Wong A, Janjan NA, Feig BW.
    Int J Radiat Oncol Biol Phys; 2004 Nov 15; 60(4):1098-105. PubMed ID: 15519780
    [Abstract] [Full Text] [Related]

  • 14. Mitomycin-C/5-fluorouracil/leucovorin and hyperfractionated radiation therapy for rectal carcinoma: a phase II study with long-term follow-up.
    Nabhan C, Ragam A, Samuels B, Milton DT, Prasad L, Hooberman A, Hartsell W, Anthony A, Weisman R, Bitran JD.
    Clin Colorectal Cancer; 2007 Mar 15; 6(6):436-41. PubMed ID: 17531107
    [Abstract] [Full Text] [Related]

  • 15. Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5-Year Clinical Outcomes ECOG-ACRIN Cancer Research Group E3204.
    Landry JC, Feng Y, Prabhu RS, Cohen SJ, Staley CA, Whittington R, Sigurdson ER, Nimeiri H, Verma U, Benson AB.
    Oncologist; 2015 Jun 15; 20(6):615-6. PubMed ID: 25926352
    [Abstract] [Full Text] [Related]

  • 16. A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group Study.
    Glynne-Jones R, Falk S, Maughan TS, Meadows HM, Sebag-Montefiore D.
    Br J Cancer; 2007 Feb 26; 96(4):551-8. PubMed ID: 17262086
    [Abstract] [Full Text] [Related]

  • 17. "Sandwich" preoperative and postoperative combined chemotherapy and radiation in tethered and fixed rectal cancer: impact of treatment intensity on local control and survival.
    Chan AK, Wong AO, Langevin JM, Jenken DA, Khoo R, Heine JA, Buie WD, Johnson DR.
    Int J Radiat Oncol Biol Phys; 1997 Feb 01; 37(3):629-37. PubMed ID: 9112462
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 79.